Effective Antimicrobial Adhesive Technology

Direct Skin-Contact Adhesive Technology Sets Us Apart

BeneHold™ CHG adhesive technology from Avery Dennison Medical integrates the antimicrobial efficacy of CHG directly into a thin adhesive layer, permitting primary skin contact and protection of the site while eliminating the need for bulky components to house the antimicrobial. A transparent carrier film keeps the CHG adhesive in contact with the skin, making it easier for clinicians to observe the site without disturbing it and more comfortable for patients compared to competitive antimicrobial dressings.  Other CHG wound dressings embed their CHG in opaque gel pads or foam disks that can be cumbersome, limit visibility of the wound site and restrict the size of the area protected.


This patented CHG adhesive platform can be customized to meet the needs of a wide range of applications and performance requirements, providing a unique opportunity to enhance any portfolio of infection control products. Customizable solutions include the option to tailor onset and duration of antimicrobial activity, adhesive thickness, adhesion level and fluid management. 


Features and Benefits

The Advantages Are Built Right In

By incorporating CHG directly into a proprietary acrylic-based adhesive, BeneHold™ CHG adhesive technology may allow for sustained antimicrobial activity across a larger protective surface area, with a thinner more conformable dressing. The technology also allows for the potential to reduce skin toxicity that may result from localized CHG concentrations in the gel pad or foam disk of competing technologies.

BeneHold™ CHG adhesive technology also offers these clinically meaningful advantages over competitive antimicrobial contact dressings.



Allows for continuous visual monitoring, reduces  unnecessary dressing changes and leaves the site protected and undisturbed


Absorption and Breathability

Manages fluids such as blood, perspiration and exudates by wicking moisture away from the site; a breathable film carrier permits additional vapor exchange




The film acts as a water-resistant, bacterial and viral barrier impenetrable to external contaminants; maintains the site as a clean, healing environment



Consistent and Sustained Antimicrobial Action

By homogeneously incorporating CHG into the adhesive, BeneHold™ CHG adhesive technology facilitates sustained inhibition of microbial growth within the dressing and prevents external contamination across the entire skin site


Custom Solutions and Future opportunities

BeneHold CHG antimicrobial adhesive technology can be customized to meet the needs of a wide range of applications and performance requirements.

If you are searching for an adhesive solution that offers the additional benefit of an antimicrobial agent, or would like more information on how you can take advantage of this unique BeneHold™ CHG adhesive technology, contact Avery Dennison Medical by completing the form below and a member of our team will contact you shortly.

Custom Solutions and Future opportunities

CHG is incorporated directly into the adhesive

Option to tailor onset and duration of antimicrobial activity

Ability to tailor the adhesive thickness, adhesion level and fluid management

Connect with us and uncover how BeneHold CHG can advance your product portfolio

  • We exclusively license the technology for specific applications and territories

  • Opportunity to bring innovation where infection prevention is of strategic focus

  • Currently expanding into Surgical and Advanced Wound Care markets

  • Open to reviewing opportunities in other areas adjacent with the right partnership opportunity